Bausch Health Companies (BHC) News Today $7.44 -0.22 (-2.81%) As of 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Bausch Health Companies Inc.: Bausch Health Statement on Selection of XIFAXAN?(rifaximin) for Inflation Reduction Act's Medicare Negotiation ProgramJanuary 17 at 4:01 PM | finanznachrichten.deXifaxan selected for CMS drug price talks in 2027January 17 at 4:01 PM | msn.comBausch Health Companies (NYSE:BHC) Sees Strong Trading Volume - Here's WhyBausch Health Companies (NYSE:BHC) Sees Large Volume Increase - Should You Buy?January 17 at 3:26 PM | marketbeat.comBausch Health Companies Inc. (NYSE:BHC) Receives Average Recommendation of "Hold" from AnalystsBausch Health Companies Inc. (NYSE:BHC - Get Free Report) has been assigned a consensus recommendation of "Hold" from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendJanuary 16 at 4:23 AM | marketbeat.comBausch Health, George Medicines sign exclusive licensing agreement or GMRx2January 14 at 5:57 AM | markets.businessinsider.comBausch + Lomb Launches enVista Aspireâ„¢ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European UnionJanuary 13, 2025 | businesswire.comGeorge Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central AmericaJanuary 13, 2025 | globenewswire.comIs Bausch Health Companies (BHC) the Best Medical Stock to Buy Under $20?January 12, 2025 | insidermonkey.com12 Best Medical Stocks To Buy Under $20January 11, 2025 | insidermonkey.comInflammX Therapeutics Announces Option Agreement with Bausch + LombJanuary 10, 2025 | globenewswire.com124,534 Shares in Bausch Health Companies Inc. (NYSE:BHC) Bought by Range Financial Group LLCRange Financial Group LLC purchased a new position in Bausch Health Companies Inc. (NYSE:BHC - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 124,534 shares of the company's stock, valuedJanuary 7, 2025 | marketbeat.comGeode Capital Management LLC Buys 108,269 Shares of Bausch Health Companies Inc. (NYSE:BHC)Geode Capital Management LLC increased its stake in shares of Bausch Health Companies Inc. (NYSE:BHC - Free Report) by 20.5% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 636,082 shares of the company's stock after purchasing an additiJanuary 4, 2025 | marketbeat.comBausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 2, 2025 | businesswire.comZacks Research Has Optimistic Outlook of BHC Q3 EarningsBausch Health Companies Inc. (NYSE:BHC - Free Report) - Equities research analysts at Zacks Research lifted their Q3 2025 earnings per share estimates for Bausch Health Companies in a research note issued to investors on Tuesday, December 17th. Zacks Research analyst R. Department now forecasts tDecember 20, 2024 | marketbeat.comZacks Research Issues Optimistic Estimate for BHC EarningsBausch Health Companies Inc. (NYSE:BHC - Free Report) - Research analysts at Zacks Research raised their Q2 2025 EPS estimates for Bausch Health Companies in a report released on Tuesday, December 17th. Zacks Research analyst R. Department now expects that the company will post earnings per shareDecember 19, 2024 | marketbeat.comIs Bausch Health Companies (BHC) Among Billionaire Paul Singer’s Top Long-Term Stock Picks?December 19, 2024 | insidermonkey.comBausch Health Companies Inc. (NYSE:BHC) Stock Position Reduced by Franklin Resources Inc.Franklin Resources Inc. cut its stake in shares of Bausch Health Companies Inc. (NYSE:BHC - Free Report) by 53.9% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,260,376 shares of the company's stock after selling 6,138,171 sharesDecember 18, 2024 | marketbeat.comBausch Health Companies Inc. (NYSE:BHC) Sees Large Increase in Short InterestBausch Health Companies Inc. (NYSE:BHC - Get Free Report) was the target of a significant increase in short interest in November. As of November 30th, there was short interest totalling 10,260,000 shares, an increase of 9.9% from the November 15th total of 9,340,000 shares. Currently, 3.5% of the shares of the stock are sold short. Based on an average daily trading volume, of 1,910,000 shares, the days-to-cover ratio is currently 5.4 days.December 15, 2024 | marketbeat.comBausch Health says Bausch + Lomb sale exploration process ‘ongoing’December 12, 2024 | markets.businessinsider.comContact lens maker Bausch + Lomb says it is exploring saleDecember 12, 2024 | reuters.comMacy's, Dave & Buster's, Bausch + Lomb And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionDecember 11, 2024 | benzinga.comXTX Topco Ltd Purchases New Position in Bausch Health Companies Inc. (NYSE:BHC)XTX Topco Ltd purchased a new stake in shares of Bausch Health Companies Inc. (NYSE:BHC - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 114,898 shares of the company's stock, valued at approximately $938,000. ODecember 11, 2024 | marketbeat.comVerition Fund Management LLC Takes Position in Bausch Health Companies Inc. (NYSE:BHC)Verition Fund Management LLC purchased a new stake in Bausch Health Companies Inc. (NYSE:BHC - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 99,028 shares of the company's stock, valued at approximately $808,December 10, 2024 | marketbeat.comBausch + Lomb And Bausch Health: Some Incremental Progress As We Wait For Sale NewsDecember 6, 2024 | seekingalpha.comCentiva Capital LP Takes $951,000 Position in Bausch Health Companies Inc. (NYSE:BHC)Centiva Capital LP bought a new position in Bausch Health Companies Inc. (NYSE:BHC - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 116,591 shares of the company's stock, valued at approximately $951,000. A number of otDecember 6, 2024 | marketbeat.comBausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness DayDecember 5, 2024 | finance.yahoo.comReadystate Asset Management LP Grows Holdings in Bausch Health Companies Inc. (NYSE:BHC)Readystate Asset Management LP grew its stake in Bausch Health Companies Inc. (NYSE:BHC - Free Report) by 38.1% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 470,761 shares of the company's stock after acquiring an additional 130,000 shares during thDecember 5, 2024 | marketbeat.comMaple Rock Capital Partners Inc. Takes Position in Bausch Health Companies Inc. (NYSE:BHC)Maple Rock Capital Partners Inc. purchased a new position in Bausch Health Companies Inc. (NYSE:BHC - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,064,900 shares of the company's stock, valued at aDecember 4, 2024 | marketbeat.comBausch Health appoints Jonathan Sadeh as CMO, head of R&DDecember 3, 2024 | markets.businessinsider.comBausch Health Companies: Improving Core Business Cures Its Bankruptcy RumorsDecember 2, 2024 | seekingalpha.comQuantbot Technologies LP Makes New $829,000 Investment in Bausch Health Companies Inc. (NYSE:BHC)Quantbot Technologies LP acquired a new stake in shares of Bausch Health Companies Inc. (NYSE:BHC - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 101,543 shares of the compaDecember 2, 2024 | marketbeat.comWhy Bausch Health Companies (BHC) is One of the Best Canadian Stock to Buy Under $10?November 30, 2024 | msn.comWhy Bausch Health Companies (BHC) is One of the Best Canadian Stocks to Buy Under $10?November 30, 2024 | msn.comBausch Health Companies Inc. (NYSE:BHC) is Goldentree Asset Management LP's Largest PositionGoldentree Asset Management LP lifted its holdings in shares of Bausch Health Companies Inc. (NYSE:BHC - Free Report) by 31.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 29,395,745 shares of the company's stock after purchasing an additioNovember 29, 2024 | marketbeat.comBank of Montreal Can Has $31.60 Million Stake in Bausch Health Companies Inc. (NYSE:BHC)Bank of Montreal Can increased its stake in shares of Bausch Health Companies Inc. (NYSE:BHC - Free Report) by 234.0% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 3,833,179 shares of the company's stock after acquiring an additional 2,685November 29, 2024 | marketbeat.comBausch Health Companies Inc. (NYSE:BHC) is favoured by institutional owners who hold 56% of the companyNovember 28, 2024 | finance.yahoo.comBausch Health Companies Inc. (NYSE:BHC) Receives Consensus Recommendation of "Hold" from BrokeragesBausch Health Companies Inc. (NYSE:BHC - Get Free Report) has been given an average rating of "Hold" by the seven analysts that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one hasNovember 27, 2024 | marketbeat.comZacks Research Has Bullish Outlook for BHC FY2024 EarningsBausch Health Companies Inc. (NYSE:BHC - Free Report) - Analysts at Zacks Research raised their FY2024 EPS estimates for Bausch Health Companies in a research report issued to clients and investors on Wednesday, November 20th. Zacks Research analyst R. Department now anticipates that the companyNovember 22, 2024 | marketbeat.comLMR Partners LLP Takes Position in Bausch Health Companies Inc. (NYSE:BHC)LMR Partners LLP purchased a new position in shares of Bausch Health Companies Inc. (NYSE:BHC - Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 400,000 shares of the company's stock, valued at approximatelyNovember 19, 2024 | marketbeat.comUS Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drugNovember 18, 2024 | reuters.comIntact Investment Management Inc. Acquires Shares of 189,000 Bausch Health Companies Inc. (NYSE:BHC)Intact Investment Management Inc. acquired a new stake in Bausch Health Companies Inc. (NYSE:BHC - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 189,000 shares of the compNovember 5, 2024 | marketbeat.comBausch Health Companies Inc. (NYSE:BHC) Given Average Rating of "Hold" by AnalystsBausch Health Companies Inc. (NYSE:BHC - Get Free Report) has received an average recommendation of "Hold" from the seven analysts that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have assigned a hold reNovember 2, 2024 | marketbeat.comBausch Health Companies (NYSE:BHC) Given New $11.00 Price Target at Royal Bank of CanadaRoyal Bank of Canada boosted their price objective on Bausch Health Companies from $10.00 to $11.00 and gave the company a "sector perform" rating in a report on Friday.November 1, 2024 | marketbeat.comEvercore ISI Keeps Their Hold Rating on Bausch Health Companies (BHC)November 1, 2024 | markets.businessinsider.comBausch Health Companies: Hold Rating Amid Mixed Financial Performance and Strategic UncertaintyNovember 1, 2024 | markets.businessinsider.comInvestors Purchase High Volume of Bausch Health Companies Put Options (NYSE:BHC)Bausch Health Companies Inc. (NYSE:BHC - Get Free Report) was the target of unusually large options trading on Thursday. Traders purchased 65,522 put options on the company. This is an increase of approximately 1,339% compared to the typical daily volume of 4,552 put options.October 31, 2024 | marketbeat.comBausch Health Companies (NYSE:BHC) Trading 8.7% Higher on Earnings BeatBausch Health Companies (NYSE:BHC) Trading Up 8.7% on Earnings BeatOctober 31, 2024 | marketbeat.comBausch Health Companies Inc. 2024 Q3 - Results - Earnings Call PresentationOctober 30, 2024 | seekingalpha.comBausch Health Companies (NYSE:BHC) Lifted to Buy at StockNews.comStockNews.com raised Bausch Health Companies from a "hold" rating to a "buy" rating in a research report on Friday.October 25, 2024 | marketbeat.comZacks Research Brokers Increase Earnings Estimates for BHCBausch Health Companies Inc. (NYSE:BHC - Free Report) - Equities research analysts at Zacks Research lifted their Q3 2026 earnings per share (EPS) estimates for shares of Bausch Health Companies in a report issued on Tuesday, October 22nd. Zacks Research analyst R. Department now anticipates thatOctober 23, 2024 | marketbeat.com Get Bausch Health Companies News Delivered to You Automatically Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter. Email Address BHC Media Mentions By Week BHC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BHC News Sentiment▼0.670.72▲Average Medical News Sentiment BHC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BHC Articles This Week▼104▲BHC Articles Average Week Get Bausch Health Companies News Delivered to You Automatically Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Qiagen News Vaxcyte News Ascendis Pharma A/S News Roivant Sciences News Revolution Medicines News Lantheus News Blueprint Medicines News BridgeBio Pharma News Legend Biotech News Elanco Animal Health News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BHC) was last updated on 1/17/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Companies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Companies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.